Insider · CIK 0001609492
MPM BioVentures 2014, L.P.
ownerother
Files at TRDA (Entrada Therapeutics, Inc.), HOWL (Werewolf Therapeutics, Inc.), ITOS (iTeos Therapeutics, Inc.). First filing Dec 12, 2024, latest Sep 9, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 14
$0 bought, $11M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
HOWL: Werewolf Therapeutics, Inc.
HOWLOct 9, 2026 · close 0.98
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
TRDA: Entrada Therapeutics, Inc.
TRDAOct 9, 2026 · close 5.67
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Entrada Therapeutics, Inc. | $1.9M 259,837 shares | -6% | - | |
| 40Moderate | Entrada Therapeutics, Inc. | $617k 86,482 shares | -2% | - | |
| 15Weak | Werewolf Therapeutics, Inc. | $183k 199,732 shares | -4% | - | |
| 18Weak | Werewolf Therapeutics, Inc. | $137k 141,927 shares | -3% | - | |
| 19Weak | Werewolf Therapeutics, Inc. | $180k 195,666 shares | -4% | - | |
| 18Weak | Werewolf Therapeutics, Inc. | $148k 160,103 shares | -3% | - | |
| 19Weak | Werewolf Therapeutics, Inc. | $201k 209,652 shares | -4% | - | |
| 20Weak | Werewolf Therapeutics, Inc. | $241k 213,529 shares | -4% | - | |
| 21Weak | Werewolf Therapeutics, Inc. | $296k 242,890 shares | -4% | - | |
| 23Weak | Werewolf Therapeutics, Inc. | $392k 295,043 shares | -5% | - | |
| 24Weak | Werewolf Therapeutics, Inc. | $446k 276,017 shares | -4% | - | |
| 53Moderate | iTeos Therapeutics, Inc. | $5.1M 630,191 shares | -23% | - | |
| 27Weak | Werewolf Therapeutics, Inc. | $2,061 1,963 shares | -0% | - | |
| 51Moderate | Entrada Therapeutics, Inc. | $917k 44,722 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -38,500 | $7.11 | $274k | 4,106,452 | 33 d ago |
| Sep 8, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -192,500 | $7.41 | $1.4M | 3,913,952 | 33 d ago |
| Sep 9, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -28,837 | $7.13 | $206k | 3,885,115 | 33 d ago |
| Sep 1, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -29,088 | $7.06 | $205k | 4,202,346 | 39 d ago |
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -25,131 | $7.19 | $181k | 4,177,215 | 39 d ago |
| Sep 3, 2026 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -32,263 | $7.17 | $231k | 4,144,952 | 39 d ago |
| Dec 2, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -59,277 | $0.89 | $53k | 4,924,566 | Dec 4, 2025 |
| Dec 3, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -57,225 | $0.87 | $50k | 4,867,341 | Dec 4, 2025 |
| Dec 4, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -83,230 | $0.97 | $81k | 4,784,111 | Dec 4, 2025 |
| Nov 26, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -60,733 | $0.98 | $60k | 5,065,037 | Dec 1, 2025 |
| Nov 28, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -20,277 | $0.99 | $20k | 5,044,760 | Dec 1, 2025 |
| Dec 1, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -60,917 | $0.94 | $57k | 4,983,843 | Dec 1, 2025 |
| Nov 21, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -64,331 | $0.83 | $53k | 5,257,105 | Nov 25, 2025 |
| Nov 24, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -88,802 | $0.98 | $87k | 5,168,303 | Nov 25, 2025 |
| Nov 25, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -42,533 | $0.92 | $39k | 5,125,770 | Nov 25, 2025 |
| Nov 18, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -52,627 | $0.93 | $49k | 5,428,912 | Nov 20, 2025 |
| Nov 19, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -66,324 | $0.94 | $62k | 5,362,588 | Nov 20, 2025 |
| Nov 20, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -41,152 | $0.89 | $37k | 5,321,436 | Nov 20, 2025 |
| Nov 13, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -90,951 | $0.98 | $89k | 5,600,240 | Nov 17, 2025 |
| Nov 14, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -61,640 | $0.93 | $57k | 5,538,600 | Nov 17, 2025 |
| Nov 17, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -57,061 | $0.95 | $54k | 5,481,539 | Nov 17, 2025 |
| Nov 7, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -68,480 | $1.11 | $76k | 5,836,240 | Nov 12, 2025 |
| Nov 10, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -48,570 | $1.18 | $57k | 5,787,670 | Nov 12, 2025 |
| Nov 11, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -55,810 | $1.14 | $64k | 5,731,860 | Nov 12, 2025 |
| Nov 12, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnotes10b5-1 | -40,669 | $1.09 | $44k | 5,691,191 | Nov 12, 2025 |
| Nov 4, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -140,488 | $1.22 | $171k | 6,007,122 | Nov 6, 2025 |
| Nov 5, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -47,950 | $1.22 | $58k | 5,959,172 | Nov 6, 2025 |
| Nov 6, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -54,452 | $1.21 | $66k | 5,904,720 | Nov 6, 2025 |
| Oct 30, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -86,936 | $1.43 | $124k | 6,355,717 | Nov 3, 2025 |
| Oct 31, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -114,044 | $1.28 | $146k | 6,241,673 | Nov 3, 2025 |
| Nov 3, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -94,063 | $1.29 | $121k | 6,147,610 | Nov 3, 2025 |
| Oct 27, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -72,709 | $1.72 | $125k | 6,645,961 | Oct 29, 2025 |
| Oct 28, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -69,068 | $1.64 | $113k | 6,576,893 | Oct 29, 2025 |
| Oct 29, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote10b5-1 | -134,240 | $1.55 | $208k | 6,442,653 | Oct 29, 2025 |
| May 13, 2025 | ITOS iTeos Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -630,191 | $8.06 | $5.1M | 2,108,594 | May 15, 2025 |
| Mar 27, 2025 | HOWL Werewolf Therapeutics, Inc. | XIn-the-money exercise Common Stockindirect: See Footnote | +22,758 | $0.09 | $2,048 | 3,210,756 | Apr 30, 2025 |
| Mar 27, 2025 | HOWL Werewolf Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -1,963 | $1.05 | $2,061 | 3,208,793 | Apr 30, 2025 |
| Mar 27, 2025 | HOWL Werewolf Therapeutics, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Footnote | -4,015 | $0.00 | $0 | 0 | Apr 30, 2025 |
| Mar 27, 2025 | HOWL Werewolf Therapeutics, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Footnote | -18,743 | $0.00 | $0 | 0 | Apr 30, 2025 |
| Dec 10, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -22,935 | $20.77 | $476k | 4,402,849 | Dec 12, 2024 |
| Dec 11, 2024 | TRDA Entrada Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See Footnote | -21,787 | $20.23 | $441k | 4,381,062 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.